These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19816798)

  • 1. Review of quantitative and qualitative studies on U.S. public perceptions of synthetic biology.
    Pauwels E
    Syst Synth Biol; 2009 Dec; 3(1-4):37-46. PubMed ID: 19816798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of problem setting and framing in citizen discussions on synthetic biology.
    Betten AW; Broerse JEW; Kupper F
    Public Underst Sci; 2018 Apr; 27(3):294-309. PubMed ID: 28597721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let's (not) talk about synthetic biology: Framing an emerging technology in public and stakeholder dialogues.
    Bauer A; Bogner A
    Public Underst Sci; 2020 Jul; 29(5):492-507. PubMed ID: 32122265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of enabling technologies in synthetic biology.
    Kahl LJ; Endy D
    J Biol Eng; 2013 May; 7(1):13. PubMed ID: 23663447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncritical and unbalanced coverage of synthetic biology in the Nordic press.
    Ancillotti M; Holmberg N; Lindfelt M; Eriksson S
    Public Underst Sci; 2017 Feb; 26(2):235-250. PubMed ID: 26481730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health.
    Schneider I
    Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining expertise: Synthetic biology experts' perceptions of risk, benefit, and the public for research and applications regulation.
    Wirz CD; Howell EL; Scheufele DA; Brossard D; Xenos MA
    Public Underst Sci; 2023 Oct; 32(7):870-888. PubMed ID: 37204058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to be prudent with synthetic biology. Synthetic Biology and the precautionary principle].
    Rodríguez López B
    Rev Derecho Genoma Hum; 2014; (41):143-66. PubMed ID: 25845210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic biology regulation and governance: Lessons from TAPIC for the United States, European Union, and Singapore.
    Trump BD
    Health Policy; 2017 Nov; 121(11):1139-1146. PubMed ID: 28807332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perception of risks and benefits of in vitro fertilization, genetic engineering and biotechnology.
    Macer DR
    Soc Sci Med; 1994 Jan; 38(1):23-33. PubMed ID: 8146712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Synthetic Biology and Biosafety Governance.
    Li J; Zhao H; Zheng L; An W
    Front Bioeng Biotechnol; 2021; 9():598087. PubMed ID: 33996776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Technology Assessment of Synthetic Biology: Fundamental and Propaedeutic Reflections in Order to Enable an Early Assessment.
    Schmidt JC
    Sci Eng Ethics; 2016 Aug; 22(4):1151-1170. PubMed ID: 26160061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Private and public values of innovation: A patent analysis of synthetic biology.
    Ribeiro B; Shapira P
    Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engaging scientists: An online survey exploring the experience of innovative biotechnological approaches to controlling vector-borne diseases.
    Boëte C; Beisel U; Reis Castro L; Césard N; Reeves RG
    Parasit Vectors; 2015 Aug; 8():414. PubMed ID: 26259589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulnerability and social justice as factors in emergent U.S. nanotechnology risk perceptions.
    Conti J; Satterfield T; Harthorn BH
    Risk Anal; 2011 Nov; 31(11):1734-48. PubMed ID: 21453374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Market power in the United States red meatpacking industry.
    Koontz SR
    Vet Clin North Am Food Anim Pract; 2003 Jul; 19(2):519-44. PubMed ID: 12951745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis health knowledge and risk perceptions among Canadian youth and young adults.
    Leos-Toro C; Fong GT; Meyer SB; Hammond D
    Harm Reduct J; 2020 Aug; 17(1):54. PubMed ID: 32746859
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.